Literature DB >> 16461922

New insights into growth hormone action.

M J Waters1, H N Hoang, D P Fairlie, R A Pelekanos, R J Brown.   

Abstract

It has been 75 years since Evans and Long identified a somatic growth-promoting substance in pituitary extracts, yet it is only in the last 20 years that the molecular basis for this action has been established. Three key elements in this elucidation were the cloning of the GH receptor, the identification of Janus kinase (JAK) 2 as the receptor-associated tyrosine kinase, and the delineation of signal transduction and activators of transcription (STAT) 5a/b as the key transcription factor(s) activated by JAK2. The interaction between these three elements results in enhanced postnatal growth and is the subject of this review. We describe a new model for GH receptor activation based on subunit rotation within a constitutive dimer, together with the phenotype and hepatic transcript profile of mice with targeted knockins to the receptor cytoplasmic domain. These support a central role for STAT5a/b in postnatal growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461922     DOI: 10.1677/jme.1.01933

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  67 in total

1.  GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebrafish transgenic model.

Authors:  Rafael Y Kuradomi; Márcio A Figueiredo; Carlos F C Lanes; Carlos E da Rosa; Daniela V Almeida; Rodrigo Maggioni; Maeli D P Silva; Luis F Marins
Journal:  Transgenic Res       Date:  2010-07-17       Impact factor: 2.788

Review 2.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 3.  Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

5.  Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples.

Authors:  Rebecca A Pelekanos; Varda S Sardesai; Marloes Dekker Nitert; Leonie K Callaway; Nicholas M Fisk; Penny L Jeffery
Journal:  Endocrine       Date:  2015-06-12       Impact factor: 3.633

6.  In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.

Authors:  Johanna L Barclay; Linda M Kerr; Leela Arthur; Jennifer E Rowland; Caroline N Nelson; Mayumi Ishikawa; Elisabetta M d'Aniello; Mary White; Peter G Noakes; Michael J Waters
Journal:  Mol Endocrinol       Date:  2009-11-02

Review 7.  Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Authors:  Peter Rotwein
Journal:  Trends Endocrinol Metab       Date:  2012-02-21       Impact factor: 12.015

8.  Endotoxin-induced growth hormone resistance in skeletal muscle.

Authors:  Yu Chen; Sumita Sood; Vidya M R Krishnamurthy; Peter Rotwein; Ralph Rabkin
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

Review 9.  Gene regulation by growth hormone.

Authors:  Peter Rotwein; Dennis J Chia
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

10.  AKT/eNOS signaling module functions as a potential feedback loop in the growth hormone signaling pathway.

Authors:  Cong-Jun Li; Theodore H Elsasser; Stanislaw Kahl
Journal:  J Mol Signal       Date:  2009-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.